Geospatial patterns of human papillomavirus vaccine uptake in Minnesota

BMJ Open

Volumn 5, Issue 8, 2015, Pages

  Nelson, Erik J ^a   Hughes, John ^b   Oakes, J Michael ^b   Pankow, James S ^b   Kulasingam, Shalini L ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; PREVALENCE; UNITED STATES; VACCINATION; YOUNG ADULT; ADOLESCENT; EPIDEMIOLOGY; MINNESOTA; PAPILLOMAVIRUS INFECTIONS; SPATIAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MINNESOTA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SPATIAL ANALYSIS; VACCINATION; YOUNG ADULT;

EID: 84941620150     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008617     Document Type: Article

References (54)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted disease among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012;61:258-61.
4. Saraiya M, Ahmed F, White M, et al. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US. Cancer 2008;113(10 Suppl):2837-40.
5. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-24.
6. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:626-9.
7. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule-United States, 2012. MMWR Morb Mortal Wkly Rep 2012;61. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a9.htm
8. Elam-Evans LD, Yankey D, Jeyarajah J, et al. Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep 2014;63:625-33.
9. Williams WW, Lu PJ, O'Halloran A, et al. Vaccination coverage among adults, excluding influenza vaccination-United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:95-102.
10. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401-11.
11. Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369:1693-702.
12. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.
13. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013;208:385-93.
14. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008;359:821-32.
15. Niccolai LM, Mehta NR, Hadler JL. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 2011;41:428-33.
16. Jeudin P, Liveright E, Del Carmen MG, et al. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther 2014;36:24-37.
17. Vadaparampil ST, Staras S A S, Malo TL, et al. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls. Cancer 2013;119:621-8.
18. Bednarczyk RA, Curran EA, Orenstein WA, et al. Health disparities in human papillomavirus vaccine coverage: trends analysis from the National Immunization Survey-Teen, 2008-2011. Clin Infect Dis 2014;58:238-41.
19. Bednarczyk RA, Birkhead GS, Morse DL, et al. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011;29:3138-43.
20. Chao C, Velicer C, Slezak JM, et al. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357-67.
21. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012;42:44-52.
22. Hertweck SP, Lajoie AS, Pinto MD, et al. Health care decision making by mothers for their adolescent daughters regarding the quadrivalent HPV vaccine. J Pediatr Adolesc Gynecol 2013;26:96-101.
23. Wei F, Moore PC, Green AL. Geographic variability in human papillomavirus vaccination among U. S. young women. Am J Prev Med 2013;44:154-7.
24. Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med 2010;38:525-33.
25. Eberth JM, Zhang X, Hossain M, et al. County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008. Tex Public Health J 2013;65:37-40.
26. Lee D. CARBayes: an R Package for Bayesian Spatial Modeling with Conditional Autoregressive Priors. J Stat Software 2013;55:1-24.
27. Rahman M, Mcgrath CJ, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among 13-17-year-old adolescent girls in the United States. Vaccine 2014;32:2394-8.
28. Nelson EJ, Hughes J, Oakes JM, et al. Estimation of geographic variation in human papillomavirus vaccine uptake in men and women: an online survey using facebook recruitment. J Med Internet Res 2014;16:e198.
29. Moran PA. Notes on continuous stochastic phenomena. Biometrika 1950;37:17-23.
30. Waller LA, Gotway CA. Applied spatial statistics for public health data. Hoboken, NJ: John Wiley & Sons, 2004.
31. Besag J, York J, Mollie A. Bayesian image restoration with two applications in spatial statistics. Ann Inst Stat Math 1991;43:1-59.
32. Lee D. A comparison of conditional autoregressive models used in Bayesian disease mapping. Spat Spatiotemporal Epidemiol 2011;2:79-89.
33. Leroux B, Lei X, Breslow N. Estimation of disease rates in small areas: a new mixed model for spatial dependence. In: Statistical models in epidemiology, the environment, and clinical trials. Halloran M, Berry D, eds. New York: Springer-Verlag, 1999:135-78.
34. Stern H, Cressie N. Inference for extremes in disease mapping. In: Disease mapping and risk assessment for public health. Lawson A, Biggeri A, Böhning D, et al, eds. John Wiley & Sons, 1999:63-84.
35. Carlin BP, Louis TA. Bayes and Empirical Bayes methods for data analysis. 2nd edn. Boca Raton: Chapman & Hall/CRC, 2000.
36. Assun\C/Cão R, Krainski E. Neighborhood dependence in Bayesian spatial models. Biom J 2009;51:851-69.
37. Besag J, Kooperberg C. On conditional and intrinsic autoregression. Biometrika 1995;82:733-46.
38. Flegal JM, Haran M, Jones GL. Markov chain Monte Carlo: can we trust the third significant figure? Stat Sci 2008;23:250-60.
39. Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 2013;119:1386-92.
40. Anhang Price R, Tiro JA, Saraiya M, et al. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011;117:5560-8.
41. Gerend MA, Shepherd JE. Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women. Women Health 2011;51:25-40.
42. Sadry SA, De Souza LR, Yudin MH. The impact of ethnicity on awareness and knowledge of and attitudes towards the human papillomavirus and vaccine among adult women. J Obstet Gynaecol Can 2013;35:995-1003.
43. Miller MK, Wickliffe J, Jahnke S, et al. Views on human papillomavirus vaccination: a mixed-methods study of urban youth. J Community Health 2014;39:835-41.
44. Skinner J, Weinstein JN, Sporer SM, et al. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med 2003;349:1350-9.
45. Baicker K, Chandra A, Skinner JS. Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med 2005;48(1 Suppl):S42-53.
46. Chen J, Rathore SS, Radford MJ, et al. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med 2001;344:1443-9.
47. Baicker K, Chandra A, Skinner JS, et al. Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff (Millwood) 2004; (Suppl Variation): VAR33-44. http://content.healthaffairs.org/content/early/2004/10/07/hlthaff.var.33.long
48. Trogdon JG, Ahn T. Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in north Carolina. Cancer Epidemiol Biomarkers Prev 2015;24:595-602.
49. Rahman M, Laz TH, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. Vaccine 2013;31:5495-9.
50. Katz ML, Reiter PL, Kluhsman BC, et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine 2009;27:3195-200.
51. Ojha RP, Tota JE, Offutt-Powell TN, et al. The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: results from the National Immunization Survey-Teen. Ann Epidemiol 2013;23:281-5.
52. Cantrell MA, Lupinacci P. Methodological issues in online data collection. J Adv Nurs 2007;60:544-9.
53. Rhodes SD, Bowie DA, Hergenrather KC. Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health 2003;57:68-73.
54. Paciorek CJ. The importance of scale for spatial-confounding bias and precision of spatial regression estimators. Stat Sci 2010;25:107-25.